SCHEMBL118013

SCHEMBL118013

C[C@@H]1Cc2cc3c(cc2C(c2ccc(N)cc2)=NN1C(=O)O)OCO3

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 3/20 0.80
GRIA1 P42261 1/20 0.80
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
CYP1A2 P05177 3/20 0.57
CYP3A4 P08684 3/20 0.57
CYP2D6 P10635 3/20 0.57
MAPT P10636 3/20 0.57
MAPK1 P28482 2/20 0.57
HSD17B10 Q99714 2/20 0.57
KDM4E B2RXH2 2/20 0.57
CYP2C9 P11712 2/20 0.57
NFKB1 P19838 2/20 0.57
CYP2C19 P33261 2/20 0.57
HIF1A Q16665 2/20 0.57
LMNA P02545 2/20 0.57
ALOX15 P16050 1/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
TDP1 Q9NUW8 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Talampanel SCHEMBL118012 0.92 GRIA2 (0.80) GRIA2GRIA1MEN1KMT2ACYP1A2
Talampanel SCHEMBL118011 0.92 GRIA2 (0.80) GRIA2GRIA1MEN1KMT2ACYP1A2
Talampanel SCHEMBL30272868 0.92 GRIA2 (0.80) GRIA2GRIA1MEN1KMT2ACYP1A2
Gyki-53655 SCHEMBL30259941 0.89 GRIA2 (1.00) GRIA2GRIA1MEN1KMT2ACYP1A2
Gyki-53655 SCHEMBL8192023 0.89 GRIA2 (1.00) GRIA2GRIA1MEN1KMT2ACYP1A2
SCHEMBL8792572 0.89 GRIA2 (0.75) GRIA2GRIA1MEN1KMT2ACYP1A2
Gyki-53655 SCHEMBL351325 0.89 GRIA2 (1.00) GRIA2GRIA1MEN1KMT2ACYP1A2
SCHEMBL8792693 0.89 GRIA2 (0.75) GRIA2GRIA1MEN1KMT2ACYP1A2
Gyki-53655 SCHEMBL25271920 0.88 GRIA2 (0.98) GRIA2GRIA1MEN1KMT2ACYP1A2
Gyki-53655 SCHEMBL30389810 0.88 GRIA2 (0.98) GRIA2GRIA1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4493 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370202-B1 XENON GAS FOR USE IN THE TREATMENT OF GLIOMAS UNIV HEIDELBERG (DE) 2026-03-18 EP claimed
US-12577255-B2 MDM2-based modulators of proteolysis and associated methods of use ARVINAS OPERATIONS, INC. (US) 2026-03-17 US claimed
EP-4704832-A2 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS Biohaven Therapeutics Ltd. (VG) 2026-03-11 EP claimed
US-20260022117-A1 COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS ARVINAS OPERATIONS INC (US) 2026-01-22 US claimed
US-12485178-B2 Bifunctional small molecules to target the selective degradation of circulating proteins YALE UNIVERSITY (US) 2025-12-02 US claimed
US-20250332274-A1 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS UNIV YALE (US) 2025-10-30 US claimed
US-12364766-B2 Bifunctional small molecules to target the selective degradation of circulating proteins YALE UNIVERSITY (US) 2025-07-22 US claimed
WO-2025088514-A1 METTL3-METTL14-COMPLEX INHIBITORS FOR THE TREATMENT OF NEUROMUSCULAR DEGENERATIVE PATHOLOGIES CAUSED BY OR LINKED TO MUTATIONS IN THE FUS GENE Università degli Studi di Roma “La Sapienza” (IT) 2025-05-01 WO claimed
CN-119591582-A Imide-based proteolytic modulators and related methods of use 阿尔维纳斯运营股份有限公司 2025-03-11 CN claimed
US-20250032503-A1 USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE HOTH THERAPEUTICS, INC. 2025-01-30 US claimed
US-20050277579-A1 Compositions for affecting weight loss KRISHNAN RANGA 2005-12-15 US claimed
WO-2005110405-A1 COMPOSITIONS FOR AFFECTING WEIGHT LOSS DUKE UNIVERSITY (US) 2005-11-24 WO claimed
US-6929801-B2 Transdermal delivery of antiparkinson agents ACRUX DDS PTY LTD (AU) 2005-08-16 US claimed
US-20050101597-A1 Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage PHARMACIA CORPORATION 2005-05-12 US claimed
WO-2005007106-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A NON-NMDA GLUTAMATE MODULATOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE PHARMACIA CORPORATION (US) 2005-01-27 WO claimed
WO-2004069195-A2 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS OF THE AIRWAYS IVAX CORPORATION (US) 2004-08-19 WO claimed
US-20040152694-A1 Methods and compositions for treating inflammatory disorders of the airways IVAX DRUG RESEARCH INSTITUTE, LTD. 2004-08-05 US claimed
US-20040013620-A1 Transdermal delivery of antiparkinson agents MONASH UNIVERSITY 2004-01-22 US claimed
US-20030073683-A1 Administration of noncompetitive AMPA receptor antagonist for neuroprotection after traumatic brain injury BELAYEV LUDMILA (US) 2003-04-17 US claimed
WO-2003024458-A1 NEUROPROTECTION AFTER TRAUMATIC BRAIN INJURY IVAX INSTITUTE FOR DRUG RESEARCH, INC. (US) 2003-03-27 WO claimed